Concepedia

Elisa ten Hacken

ET

23

Publications

1.7K

Citations

21

H-Index

2010

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

The University of Texas MD Anderson Cancer Center

Harvard University

Vita-Salute San Raffaele University

Broad Institute

Elisa ten Hacken is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

2010–2022

23

Publications

23

Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies

Romain Guièze, Vivian M. Liu, Daniel Rosebrock et al. · Cancer Cell · 2019 · 348 citations · Full text

, , +9

Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers

Francesca Cottini, Teru Hideshima, Chunxiao Xu et al. · Nature Medicine · 2014 · 308 citations · Full text

Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia

Stefania Fiorcari, Rossana Maffei, Valentina Audrito et al. · Oncotarget · 2016 · 101 citations · Full text

A Murine Model of Chronic Lymphocytic Leukemia Based on B Cell-Restricted Expression of Sf3b1 Mutation and Atm Deletion

Shanye Yin, Rutendo Gambe, Jing Sun et al. · Cancer Cell · 2019 · 94 citations · Full text

Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia

Erika Tissino, Dania Benedetti, Sarah E. M. Herman et al. · The Journal of Experimental Medicine · 2018 · 90 citations · Full text

Rows per page

1–5 of 23